Lexicon Pharmaceuticals, Inc.
LXRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001062822
No open-market purchases or sales by Lexicon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 149 institutions reported holding it in 13F filings for Q2 2026, worth $875.1M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Lexicon Pharmaceuticals, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 123 | 1 | 124 | +2 |
| Shares | 256.3M | 11.7K | 255.1M | −1.13M (−0.4%) |
| Value | $242.9M | $11.1K | $344.4M | +$101.5M (+41.8%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Lexicon Pharmaceuticals, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 2,634,027 | $3.56M | 0.00% |
| Jacobs Levy Equity Management, Inc | 692,727 | $935.2K | 0.00% |
| Renaissance Technologies LLC | 292,400 | $394.7K | 0.00% |
| Quadrature Capital Ltd | 228,209 | $309.2K | 0.00% |
| Jefferies Financial Group Inc. | 97,400 | $131.5K | 0.00% |
| Headlands Technologies LLC | 49,647 | $67.0K | 0.01% |
| Acadian Asset Management LLC | 36,905 | $49.0K | 0.00% |
| Prudential Financial Inc | 35,000 | $47.2K | 0.00% |
| Wolverine Trading, LLC | 21,191 | $29.5K | 0.00% |
| Cetera Investment Advisers | 17,524 | $23.7K | 0.00% |
| State of Wyoming | 8,526 | $11.5K | 0.00% |
| GF Fund Management Co. Ltd. | 7,818 | $10.6K | 0.00% |
| SRS Capital Advisors, Inc. | 5,097 | $6.88K | 0.00% |
| Advisory Services Network, LLC | 3,242 | $4.38K | 0.00% |
| Caitong International Asset Management Co., Ltd | 959 | $1.29K | 0.00% |
| Federation des caisses Desjardins du Quebec | 571 | $771 | 0.00% |
| TFC Financial Management | 500 | $675 | 0.00% |
| Rockefeller Capital Management L.P. | 335 | $452 | 0.00% |
| Rhumbline Advisers | 0 | $2 | 0.00% |
Sold out (17)
Institutions that held Lexicon Pharmaceuticals, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Wellington Management Group LLP | 486,674 | $460.2K |
| Jain Global LLC | 151,813 | $143.6K |
| Virtu Financial LLC | 146,805 | $139.0K |
| Aster Capital Management (DIFC) Ltd | 130,452 | $123.4K |
| Quantessence Capital LLC | 84,098 | $79.5K |
| Pallas Capital Advisors LLC | 36,765 | $34.8K |
| Hudson Bay Capital Management LP | 27,010 | $25.5K |
| D. E. Shaw & Co., Inc. | 23,723 | $22.4K |
| Merit Financial Group, LLC | 16,699 | $15.8K |
| Integrated Wealth Concepts LLC | 16,210 | $15.3K |
| Jump Financial, LLC | 15,993 | $15.1K |
| HighTower Advisors, LLC | 14,910 | $14.1K |
| Buckingham Strategic Partners | 13,746 | $13.0K |
| ExodusPoint Capital Management, LP | 12,241 | $12.0K |
| Raymond James Financial Inc | 2,076 | $1.96K |
| Quintet Private Bank (Europe) S.A. | 1,928 | $1.82K |
| CBIZ Investment Advisory Services, LLC | 71 | $67 |
Not filed for Q3 2025 yet (1)
Institutions that held Lexicon Pharmaceuticals, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Avantax Advisory Services, Inc. | 11,724 | $11.1K |